Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I Just got this TimSykes email
This 10 cent stock DOUBLED in 1 day
On April 15th, Jaguar Health (JAGX) was trading for around $0.10 cents per share.
Because it’s a penny stock, no one was paying attention to it.
But our new AI system sensed a BIG move coming…
So the AI sent out an immediate buy signal.
And sure enough…
Just 1 day later…
JAGX ripped from $0.10 cents to $0.25 cents for an ultra fast 150% gain.
You might think that’s a “once in a blue moon” type of thing.
And you’d be right for most stocks.
For example, it took Nvidia the past 6 months to double in price, and that’s one of the fastest moving large caps in the market.
But for penny stocks like JAGX…
Doubling in price really fast is far more common than you’d think.
That’s why I absolutely love trading penny stocks, and will NEVER shut up about this strategy.
Because I’ve been able to turn $12.4k into over $7.6 Million career profits…
And I’ve helped 40 others become Millionaires too…
But if you want to learn our exact strategy…
Go here now to discover my simple secret to trading penny stocks that gain 150%+ in 1 day.
- Tim Sykes
?
?
66 West Flagler Street STE 900
Miami, Florida 33130
United States
Facebook Twitter Instagram YouTube
Click Here to Unsubscribe
1. Results are not typical. I teach methods that have made other traders money, but that does not guarantee you will make any money. Success in trading requires hard work and dedication. Past performance does not indicate future results. All trading carries risks.
**Timothy Sykes teaches skills others have used to make money. Any results displayed are extraordinary and are not typical and will vary from person to person. For more info read our Earning Claims Disclosure
About: Making money trading stocks takes time, dedication, and hard work. My goal is to teach you how I have succeeded in the market, but you may not achieve my results. Remember, there are risks involved with investing, including the potential loss of money.
We are strongly committed to protecting your privacy and providing a safe & high-quality online experience for all of our visitors. We understand that you care about how the information you provide to us is used and shared. We have developed a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from users of our website.
Our Privacy Policy, along with our Term & Conditions, governs your use of this site. By using our site, or by accepting the Terms of Use (via opt-in, checkbox, pop-up, or clicking an email link confirming the same), you agree to be bound by our Terms & Conditions and our Privacy Policy.
If you have provided personal, billing, or other voluntarily provided information, you may access, review, and make changes to it via instructions found on the Website or by replying to this email. To manage your receipt of marketing and non-transactional communications, you may unsubscribe by clicking the “unsubscribe” link located on the bottom of any marketing email. Emails related to the purchase or delivery of orders are provided automatically – Customers are not able to opt out of transactional emails. We will try to accommodate any requests related to the management of Personal Information in a timely manner. However, it is not always possible to completely remove or modify information in our databases (for example, if we have a legal obligation to keep it for certain timeframes, for example).
If you have any questions, simply reply to this email or visit our website to view our official policies.
**
JAGX..........................................https://stockcharts.com/h-sc/ui?s=JAGX&p=W&b=5&g=0&id=p86431144783
Actually huge dump from the high!!!!
JAGX chart looks like a Nike swoosh symbol about to form a bowl Tcup whatever you wanna call it all points to positive. We can’t all be this stupid as investors says 141 milly shares traded that’s neat… battle again on Monday!!!!! Peace out!
JAGX is a great $$$$$ opportunity. So many positive fundamentals and technical indicators.
I was really excited about the quick rise to .36. I guess some profit takers for the weekend. Timber wolf must of had quick a few. Gave it a quite a dip at 11. But I’ll take a dime increase in one week. Maybe some big news next week.
Another green close tee hee :)
JAGX
POWER HOUR IN 47 minutes! Let’s see a strong close! Above .36!!!!
I thought this was just a flipping stock!!!?
That surge in volume out of nowhere wow JAGX setting up nicely for next week action 🚀
Market roaring, expecting 2 drops this year in the cards. LISA is very quiet... something big is coming :)
They don’t invest just to lose money….
Hedge Funds Weigh In On Jaguar Health
Hedge funds have recently made changes to their positions in the business. Citigroup Inc. bought a new position in shares of Jaguar Health in the first quarter worth about $34,000. Goldman Sachs Group Inc. boosted its stake in shares of Jaguar Health by 153.3% in the first quarter. Goldman Sachs Group Inc. now owns 54,770 shares of the biotechnology company’s stock worth $39,000 after acquiring an additional 33,148 shares during the period. Acadian Asset Management LLC bought a new position in shares of Jaguar Health in the first quarter worth about $43,000. Geode Capital Management LLC bought a new position in shares of Jaguar Health in the second quarter worth about $48,000. Finally, Bank of New York Mellon Corp lifted its position in shares of Jaguar Health by 507.3% in the first quarter. Bank of New York Mellon Corp now owns 169,749 shares of the biotechnology company’s stock worth $120,000 after buying an additional 141,796 shares in the last quarter. Institutional investors own 12.04% of the company’s stock.
Look at that volume
I think the last hour should be up, getting ready (collecting) for next week, imho
0.21... lol. I would consider myself lucky if i'll ever get a change of buying at 0.26. Today was close, but i wanted more, and look where it's now...*sigh*
Think all the predictions forgot to account for the RS…. lol
HOLY SHI_T NEW HIGHS COMING BOOOOOOOOOOOOOM
imho
123 milly shares not even NOON cst !!!! SOLID!
Looking good knrorrel!
Rolling the dice for another JAGXZEE 🎲 🎲 🎲 🎲 🎲
$JAGX
$JAGX 🔥🔥🔥🔥 just starting to move to new and higher levels and new highs 🚀🚀🚀
imo
$JAGX is about to go back up WOW BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM
No worries here the trend is our friend ➡️↗️
JAGX
If I hadn't had to do something this morn on the open, I would have taken the 33 cents plus. But decided to sell out when I got home at 30.25 cents/sh..
Why? 1. I bought it for the 'trade' in a take what it gives approach.
2. I wanted to be in for the PH 3 data release, but it got too chaotic again, too euphoric and they tend to 'pull back to an undetermined depth that is to be determined.
3. So took what it gave, and am watching. Note, when I sold my shares, they were 'taken' in very small lots vs all or nearly all of the shares going at once. Told me there was a lack of buyers when I sold to absorb them.
4. And see some buyers stepped in around 28 cents/sh. As is the norm in these pullbacks, there will be some that see it as cheap relative to where it 'just was (35 cents this morn) and put a pause in the pullback.
5. The unknown is how many buyers are there vs those holding wondering if they should take what it gave as well.
6. I plan to reload IF the price dips to 22 cents or less, ie, down where its CURRENT MOVING AVERAGE line is. I am a believer that the share price and its MA line like to get together and when they get too far apart, they get lonely and try to get together again.
and at the moment, the MA line for the time period I use is around 21 cents. So the question is, where will they decide to meet each other at now..
GOOD LUCK... again, I would like to own the shares again, but will be patient to see when that happens. And if I miss out, mis-read the strength of this move up from 12 cents (my first buy of shares), won't be the first time that happened.
Still a bit low for most people's average.
Don't worry, people need money for their weekend shopping and will sell in the last 10 minutes before the end of trading if JAGX starts to move up again.
lol
imho
6 times profits 600% I can not be more greedy I am out for real this time and good luck y’all
MANNNNN WONDER HOW MANY BUY ORDERS ARE PLACE AT OPENING...LOL....JAGX$$$$$$$$$$$
ANY MINUTE NOW B4 OPENING THEY GONNA SAY THE HELL WITH IT....I WANT IN!!!...WEVE ALL BEEN THERE.....JAGX$$$$$$$$$$$$$$$$$$$
Went almost to .37 and brought it down quickly. Don’t think they’ll be able to hold her down when the regular market opens! She’s about to blow!!!
LOOKS LIKE JAGX IS READY TO RIP AGAIN!!$$
Im amazed it didnt gap today but slow steady we go...Thanks for that solid DD :)
JAGX
It is just not split adjusted
LOL with 276,000,000 Total Shares Outstanding x lowest target of that article:
276,000,000 x lowest target of $421.92 of that article = $116,449,920,000 ?
🤪
$JAGX
Targets can change 'very quickly' depending on news/progress etc! IMHO
GLTA $JAGX
Day 2 it's 1pm what's today's agenda at the conference!?
DAY 2 | FRIDAY | 3 MAY 2024
07:00 Onsite Registration
08:00 - 10:10 Session 3: Clinical Practice
10:10 - 10:30 Poster Session, Coffee Break & Exhibits
10:30 - 12:35 Session 4: Keynote Lectures
12:35 - 13:00 Opening Ceremony
13:00 - 14:30 Prayer & Lunch
Almost over for them to go buy more 🐂
2 other firms put a $6 PT on this thing. Are you living under a rock or can you see a billion dollar drug market when you see it?
That would be something...
=============
12-Month JAGX Price Target
Average 612.82 (+208909.54% Upside)
Jaguar Health Inc Stock (JAGX) Forecast
The Jaguar Health Inc (JAGX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $477.11, representing a +162623.67% increase from the current price of $0.2932. The highest analyst price target is $532.29, and the lowest is $421.92.
https://stockscan.io/stocks/JAGX/forecast
=============
What does 'the author' of this article take... with the coffee ☕️? LOL
$JAGX
.345.
Pre market
despite shorts - there is such a massive increase on $JAGX, that is absolutely strong and that just shows!!! how much purchasing power and euphoria has just arisen with JAGX and many people recognize the potential
and not even the shorts can stop $JAGX now (just slow it down slightly - lol)
I don't want to imagine if the shorts give up and cover...... well then holy MOLY
but that is not a buy recommendation
imho
http://shortvolumes.com/?t=JAGX+
and fantastic news here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174349974
JAGX is just getting started and I wonder where JAGX will end up, certainly in dollar land, imho
thx for the great News , sounds fantastic
Jaguar Health has signed a binding term sheet covering the exclusive license and commercialization agreement for Jaguar’s novel plant-based, FDA-approved prescription drug crofelemer with Turkish specialty pharmaceutical company Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret. The Agreement will entail a $2 million investment by GEN in Jaguar stock at a 75% premium to the market price, payment of double-digit royalties to Jaguar on all finished crofelemer products sold in the licensed territory, and transfer pricing terms for crofelemer supplied by Jaguar. As a result of this investment, GEN will own 6.7% of the shares of Jaguar common stock outstanding as of March 18, 2024. The Agreement will cover Jaguar’s FDA-approved indication of crofelemer for HIV-related diarrhea and all potential crofelemer follow-on indications, including cancer therapy-related diarrhea – the subject of Jaguar’s placebo-controlled pivotal Phase 3 OnTarget trial, as well as the rare disease indications short bowel syndrome and microvillus inclusion disease, and any other possible future human indications for crofelemer. The Agreement will allow GEN to manufacture crofelemer finished product and market the drug for all above-referenced indications in Turkey, Belarus, Ukraine, Azerbaijan, Uzbekistan, Kazakhstan, Turkmenistan, Russia, and Georgia following GEN’s receipt of regulatory approval for crofelemer for these indications in these countries
Another great day here for sure.
HKD did crazy squeeze but JAGX at $425 in month????? Sure I’m in lol
Followers
|
140
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6956
|
Created
|
12/01/15
|
Type
|
Free
|
Moderators crudeoil24 SmellMyFinger |
Jaguar Health, Inc. $JAGX
Bringing Plant-based Medicines to Life™
Pharmaceutical Manufacturing
San Francisco, California
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Products:
Mytesi Crofelemer 125mg delayed release tablets
Mytesi is FDA-approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy
Mytesi has a novel mechanism of action that modulates chloride secretion in the gastrointestinal tract, reducing excessive chloride and accompanying water flow and relieving watery diarrhea.
Mytesi is not indicated for the treatment of infectious diarrhea. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).
Canalevia-CA1 Crofelemer delayed release tablets
Distributors listed:
https://www.canalevia.com/distributor-information
CANALEVIA-CA1 is conditionally approved for the treatment of chemotherapy-induced diarrhea (CID) in dogs.
Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling.
Pipeline: https://jaguar.health/pipeline/
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.
Jaguar Health https://jaguar.health/
Napo Pharmaceuticals https://napopharma.com/
Napo Therapeutics https://napotherapeutics.com/en/
https://www.magdalenabiosciences.com/
Magdalena is a joint venture formed by Jaguar Health and Filament Health. The company holds an exclusive license to Jaguar's proprietary library of approximately 2,300 highly characterized medicinal plants and 3,500 plant extracts for designated therapeutic indications.
Visit Jaguar on LinkedIn:
https://www.linkedin.com/company/jaguar-health/
Visit Jaguar on Instagram: https://www.instagram.com/jaguarhealthcommunity/
Visit Jaguar on X: https://twitter.com/Jaguar_Health
Phone: 415-371-8300
Contact: hello@jaguar.health
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |